Sodium Picosulfate能抑制水和电解质的吸收,增加它们的分泌。
Sodium Picosulfate inhibits absorption of water and electrolytes, and increases their secretion.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Nishikawa J, et al. Arzneimittelforschung, 1981, 31(2), 321-325.
[2] Fioramonti, J., C. Dupuy, and L. Bueno, In vivo motility of rat colon chronically pretreated with sennosides. Pharmacology, 1993. 47 Suppl 1: p. 155-61.
[3] Geboes, K., et al., Effects of 'contact laxatives' on intestinal and colonic epithelial cell proliferation. Pharmacology, 1993. 47 Suppl 1: p. 187-95.
分子式 C18H13NNa2O8S2 |
分子量 481.41 |
CAS号 10040-45-6 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 100 mg/mL |
Water 100 mg/mL |
Ethanol 5 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01292109 | Bowel Cleanliness | Drug: sodium picosulphate | Ferring Pharmaceuticals | 2010-12-01 | 2012-02-08 | |
NCT03074448 | Bowel Preparation | Device: Aquanet|Drug: Sodium Picosulfate | Kaiser Clinic and Hospital | Phase 3 | 2014-05-01 | 2017-03-03 |
NCT01685970 | Colonoscopy | Drug: High volume split-dose PEG|Drug: 2 sachets of picosulfate | Inje University | Phase 3 | 2012-09-01 | 2012-09-14 |
NCT02979223 | Bowel Preperation|Sodium Picosulfate and Magnesium Citrate|Polyethylene Glycol With Ascorbic Acid | Drug: sodium picosulfate and magnesium citrate, polyethylene glycol with ascorbic acid | National Cancer Center, Korea | Phase 2 | 2016-11-01 | 2016-12-04 |
NCT01603654 | Colon Cleansing for Colonoscopy | Drug: sodium picosulphate magnesium citrate|Drug: low-volume PEG -ascorbic acid | Ospedale L. Sacco 鈥?Polo Universitario | Phase 4 | 2011-01-01 | 2012-05-21 |
NCT02211911 | Healthy | Drug: Bisacodyl|Drug: Sodium picosulfate | Boehringer Ingelheim | Phase 1 | 2008-02-01 | 2014-08-07 |
NCT01093274 | Bowel Preparation | Drug: Sodium Picosulphate|Drug: Polyethylene Glycol | Rabin Medical Center | 2010-03-24 | ||
NCT00576810 | Constipation | Drug: sodium picosulphate | Boehringer Ingelheim | Phase 3 | 2007-10-01 | 2014-04-30 |
NCT03017235 | Bowel Preparation | Drug: Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution|Drug: Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Powder | Ferring Pharmaceuticals | Phase 3 | 2017-01-01 | 2017-01-16 |
NCT01778192 | Colorectal Cancer|Colon Adenoma | Drug: Polyethylene glycol|Drug: Polyethylene glycol|Drug: Sodium picosulphate with magnesium citrate|Drug: Sodium picosulphate with magnesium citrate | Korea University Anam Hospital | Phase 3 | 2012-07-01 | 2013-01-29 |
NCT01481714 | Bowel Cleansing|Colonoscopy | Drug: Sodium picosulphate, magnesium oxid and citric acid|Drug: Sodium picosulphate/magnesium oxide and citric acid | Infante, Javier Molina, M.D. | Phase 4 | 2011-11-01 | 2011-11-28 |
NCT02239692 | Bowel Cleansing | Drug: PICOPREP | Ferring Pharmaceuticals | Phase 3 | 2014-11-01 | 2016-05-17 |
NCT01909219 | Colon Cleansing | Drug: Sodium picosulphate/magnesium Citrate | Luigi Sacco University Hospital | Phase 4 | 2012-01-01 | 2013-07-25 |
NCT02386449 | Bowel Preparation | Drug: sodium picosulfate, magnesium oxide and citric acid (Picoprep庐)|Drug: mannitol|Drug: Bisacodyl | Ferring Pharmaceuticals | Phase 4 | 2015-02-01 | 2016-01-11 |
NCT01073943 | Bowel Preparation | Drug: PicoPrep|Drug: HalfLytely|Drug: bisacodyl | Ferring Pharmaceuticals | Phase 3 | 2010-05-01 | 2012-10-23 |
NCT01073930 | Bowel Preparation | Drug: PicoPrep|Drug: HalfLytely|Drug: bisacodyl | Ferring Pharmaceuticals | Phase 3 | 2010-05-01 | 2013-02-11 |
NCT01065857 | Subjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time. | Drug: Sodium picosulphate, light magnesium oxide and anhydride citric acid.|Drug: Polyethylene glycol, KCl, NaCl, sodium sulphate anhydrous and sodium bicarbonate. | Laboratorios Casen-Fleet S.L.U.|Trial Form Support S.L.|Apices Soluciones S.L. | Phase 3 | 2010-01-01 | 2011-04-14 |
NCT01356407 | Colonoscopy | Drug: PICOPREP|Drug: PEG-ELS | Ferring Pharmaceuticals | Phase 3 | 2011-01-01 | 2012-12-17 |
NCT02273141 | Colorectal Cancer | Drug: NER1006, Day Before-Only Dosing|Drug: SP+MS, Day Before-Only Dosing | Norgine | Phase 3 | 2014-11-01 | 2016-01-18 |
NCT01748591 | Bowel Cleanliness | Ferring Pharmaceuticals | 2012-05-01 | 2015-12-21 | ||
NCT00312481 | Colonoscopy | Drug: macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate|Drug: NA picosulfate magnesium citrate | Norgine | Phase 2 | 2005-07-01 | 2007-12-12 |
NCT02024022 | Bowel Cleansing Process|Colonoscopy | Drug: Standard approach|Drug: Individualized approach | Clinical Hospital Colentina | Phase 4 | 2014-02-01 | 2016-01-26 |
NCT01689792 | Colorectal Cancer | Drug: MOVIPREP|Drug: CitraFleet | Norgine | Phase 4 | 2011-11-01 | 2015-03-30 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们